1. Academic Validation
  2. Prefusion-stabilized Hantaan virus glycoprotein nucleic acid vaccine elicits potent neutralizing antibody responses via germinal center activation

Prefusion-stabilized Hantaan virus glycoprotein nucleic acid vaccine elicits potent neutralizing antibody responses via germinal center activation

  • Nat Commun. 2026 Mar 14;17(1):3972. doi: 10.1038/s41467-026-70285-7.
Wei Ye # 1 Yamei Dang # 2 Yuan Wang # 2 Qiqi Yang # 2 Hui Zhang # 2 Chuantao Ye # 3 Jing Wei # 2 4 Jiawei Pei 2 Xuemin Pei 2 5 Dongshen Jiang 2 6 Xiaojing Yang 2 6 Xiaolei Jin 7 Hongwei Ma 2 He Liu 2 Liang Zhang 2 Linfeng Cheng 2 Yangchao Dong 2 Yingfeng Lei 8 Zhikai Xu 9 Fanglin Zhang 10
Affiliations

Affiliations

  • 1 Department of Microbiology, School of Basic Medicine, Airforce Medical University: Fourth Military Medical University, Xi'an, Shaanxi, China. [email protected].
  • 2 Department of Microbiology, School of Basic Medicine, Airforce Medical University: Fourth Military Medical University, Xi'an, Shaanxi, China.
  • 3 Department of Infectious Diseases, Tangdu Hospital, Airforce Medical University: Fourth Military Medical University, Xi'an, Shaanxi, China.
  • 4 Center for Disease Control and Prevention of Shaanxi Province, Xi'an, Shaanxi, China.
  • 5 School of Medicine, Northwest University, Xi'an, Shaanxi, China.
  • 6 School of Medicine, Yan'an University, Yan'an, Shaanxi, China.
  • 7 Student Brigade, School of Basic Medicine, Airforce Medical University: Fourth Military Medical University, Xi'an, Shaanxi, China.
  • 8 Department of Microbiology, School of Basic Medicine, Airforce Medical University: Fourth Military Medical University, Xi'an, Shaanxi, China. [email protected].
  • 9 Department of Microbiology, School of Basic Medicine, Airforce Medical University: Fourth Military Medical University, Xi'an, Shaanxi, China. [email protected].
  • 10 Department of Microbiology, School of Basic Medicine, Airforce Medical University: Fourth Military Medical University, Xi'an, Shaanxi, China. [email protected].
  • # Contributed equally.
Abstract

Old World orthohantaviruses, including Hantaan virus (HTNV), cause hemorrhagic fever with renal syndrome (HFRS) in Eurasia. Available inactivated vaccines often induce low neutralizing antibodies and short-term protection. We evaluated nucleic acid vaccines expressing a prefusion-stabilized HTNV glycoprotein in female BALB/c mice. Both DNA and mRNA-LNP versions elicited robust neutralizing antibodies by strongly activating germinal centers, which protected mice against high-dose HTNV challenge. We further tested heterologous prime-boost regimens, where mice primed with inactivated vaccine received different boosters. All boosters increased neutralizing titers, but only the prefusion-stabilized glycoprotein mRNA-LNP vaccine raised titers to the level achieved by its own full primary vaccination course. This demonstrates the immunogen's superiority in developing next-generation vaccines and its unique ability to potently recall memory B cells induced by suboptimal inactivated vaccines. Thus, prefusion-stabilized glycoprotein-based nucleic acid vaccines are promising candidates for advanced orthohantavirus vaccine development.

Figures
Products